Navigation Links
Rabbit Anti-Nck alpha Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human CD182 (CXCR2) Monoclonal Antibody, Unconjugated, Clone 5E8/CXCR2 from BioLegend
Rabbit Anti-Human Purinergic Receptor P2Y12 Polyclonal Antibody, Unconjugated from IMGENEX
Goat Anti-Human AGAP1 / Centaurin, gamma 2 Polyclonal Antibody, Unconjugated from IMGENEX
Rabbit Anti-Human CLAN Polyclonal Antibody, Unconjugated from IMGENEX
Biology Products:
(Date:11/23/2009)...des "incontrovertible evidence" that the volcanic ...out 73,000 years ago deforested much of central In...ers report. , The volcano ejected an estimated 8...aving a crater (now the world,s largest volcanic l... wide. Ash from the event has been found in India,...
(Date:11/23/2009)...USDOE and USDA study concluded that 50 million U.S...asture could be converted from current uses to the...ass, from which biomass could be harvested for use...ction of a perennial grass monoculture from which ...ally is expected to require nitrogen fertilizer. ,...
(Date:11/23/2009)...eal in unprecedented detail how the ribosome inter... and guide them toward their destination in biolog...exible fitting (MDFF) to examine the interaction o...rs. , The first study, in Proceedings of the N...e signaling between the ribosome and an elongation...
Breaking Biology News(10 mins):Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Switchgrass produces biomass efficiently 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years 3A DURATION 1 Interim Long Term Data Present 4551 1Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years 3A DURATION 1 Interim Long Term Data Present 4551 2Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years 3A DURATION 1 Interim Long Term Data Present 4551 3Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years 3A DURATION 1 Interim Long Term Data Present 4551 4Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years 3A DURATION 1 Interim Long Term Data Present 4551 5Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years 3A DURATION 1 Interim Long Term Data Present 4551 6Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years 3A DURATION 1 Interim Long Term Data Present 4551 7Study Shows GSKs Novel Diabetes Treatment SYNCRIA 28R 29 28albiglutide 29 Improves Glucose Control and Reduces Weight 4549 1Study Shows GSKs Novel Diabetes Treatment SYNCRIA 28R 29 28albiglutide 29 Improves Glucose Control and Reduces Weight 4549 2Study Shows GSKs Novel Diabetes Treatment SYNCRIA 28R 29 28albiglutide 29 Improves Glucose Control and Reduces Weight 4549 3Orange County Laser Surgeon Nissan Pilest Tapped as Keynote Speaker at Fraxel 26amp 3B Thermage User Forum Held at Beckman Laser Institute 12498 1Orange County Laser Surgeon Nissan Pilest Tapped as Keynote Speaker at Fraxel 26amp 3B Thermage User Forum Held at Beckman Laser Institute 12498 2Orange County Laser Surgeon Nissan Pilest Tapped as Keynote Speaker at Fraxel 26amp 3B Thermage User Forum Held at Beckman Laser Institute 12498 3
... In recent years, a growing scarcity of energy com...ey geopolitical risks and threats, such as conflic...nalism. However, a study released this week by Ric...uggests that, taken individually, many of the risk...rophic than they seem at first glance. The executi...
... Fishery biologist Sandy Sutherland looks through ...h earbones, known as otoliths, each showing annual...o determine the age of the fish, then moves on to ...nd is one of a small team at NOAAs Northeast Fishe...itical to stock assessments needed to manage the n...
... This press release is available in German . , ...cost us in the long term" How much do national eco...nd" And what price will we have to pay if we do no...nomics of Ecosystems and Biodiversity - project is...ukhdev, who is head of Deutsche Bank,s Global Mark...
Other Biology News:Baker Institute study, conference weigh risks for global energy markets 2Saltwater sleuths: Seeking clues to help determine the ages of fish and shellfish populations 2Saltwater sleuths: Seeking clues to help determine the ages of fish and shellfish populations 3Saltwater sleuths: Seeking clues to help determine the ages of fish and shellfish populations 4Biodiversity as a natural resource 2
(Date:11/24/2009)...RNewswire/--HealthRoboticstodayannounced,thatithas...,investors.ThisrecentlyformedToronto-basedcompanyw...dwillmarket,install,andsupport,HealthRobotics,i.v....aryproductofferingsi.v.STATION(TM),i.v.SOFT(TM),an...ssistanceonan"asneeded,basis"toitsstrategicpartner...
(Date:11/24/2009)...e-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasdaqand...JaffrayHealthCareConference.Theconferencewillbehel...TIwillpresentonTuesday,December1at11:00a.m.Eastern...esentationwillbeavailableat www.celltherapeutics.c... ,PiperJaffrayHealthCareConference,NewYorkPalaceH...
(Date:11/23/2009)...ra-fast communication, computation and more powerf...ng to use quantum states as carriers of informatio...cists have shown, mathematically, how to gently te...hile keeping the information intact. Their work is... Letters and highlighted with a Viewpoint in Phy...
(Date:11/23/2009)...Newswire-FirstCall/-YMBioSciencesInc.(NYSEAmex: YM...hatidentifiesandadvancesadiverseportfolioofpromisi...nt,todayreportedthatCytopia(ASX:CYT)hascommenceden...orally-administeredJAK1/JAK2inhibitor.Thetrialisbe...posaltomergeCytopiaintoYMhasbeenpreviouslyannounce...
Breaking Biology Technology:Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4